Related Experiment Video
Updated: May 17, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Circulating thrombotic and haemostatic components in patients with coronary artery disease
Kavita K Shalia1, V K Shah, M R Mashru
1H. N. Medical Research Society, Sir H. N. Hospital and Research Centre, Raja Rammohan Roy Road, Mumbai, 400 004 India.
Insights
This study found elevated tissue factor (TF) in acute myocardial infarction, unstable angina, and stable angina patients compared to healthy individuals. This indicates a procoagulant state across these cardiovascular conditions.
Area of Science:
- Cardiovascular Medicine
- Hemostasis and Thrombosis
- Biochemistry
Background:
- Thrombotic and hemostatic factors play a crucial role in cardiovascular diseases.
- Understanding these components is vital for diagnosing and managing conditions like myocardial infarction and angina.
Purpose of the Study:
- To analyze circulating levels of key thrombotic and hemostatic components.
- To compare these levels in patients with acute myocardial infarction, unstable angina, stable angina, and healthy controls.
Main Methods:
- Measurement of tissue factor (TF), tissue factor pathway inhibitor (TFPI), tissue plasminogen activator (t-PA), and plasminogen activator inhibitor-1 (PAI-1).
- Comparison of levels across four groups: acute MI, post-treatment unstable angina/NSTEMI, stable angina, and healthy individuals.
Main Results:
- Significantly increased TF levels were observed in acute MI (2.0-fold), unstable angina (2.2-fold), and stable angina (1.8-fold) groups compared to controls.
- Plasminogen activator inhibitor-1 (PAI-1) significantly increased in the acute MI group (35.8%).
- TFPI and t-PA increased in younger (<40 years) acute MI patients, with insignificant changes in older patients, suggesting age-related differences.
Conclusions:
- Acute myocardial infarction patients exhibit increased thrombotic and decreased fibrinolytic conditions.
- Elevated TF in stable angina patients suggests a procoagulant status even in less acute phases.
- Findings highlight the complex role of hemostatic factors in different stages of coronary artery disease.
Abstract:
The study aimed to analyze the circulating levels of thrombotic and haemostatic components; tissue factor, tissue factor pathway inhibitor, tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with acute myocardial infarction at presentation (Group 1, n=49), unstable angina and Non-ST elevated MI after treatment (Group 2, n=22), stable angina (Group 3, n=18) and healthy individuals (Group 4, n=31). Significant finding was increase in tissue factor not only in Group 1 (2.0 fold, P=0.001), Group 2 (2.2 fold, P=0.015) but also in Group 3 (1.8 fold, P=0.018) as compared to controls. In Group 1 Plasminogen activator inhibitor-1 increased significantly (35.8%, P=0.02). Tissue factor pathway inhibitor and tissue plasminogen activator demonstrated increase in Group 1 of age<40 years while insignificant changes in elder patients. Increased thrombotic and decreased fibrinolytic conditions in acute myocardial infarction patients were observed. Increase TF in stable angina demonstrates procoagulant status in these patients as well.
More Related Videos
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Coronary Artery Disease II: Pathophysiology
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
Coronary Circulation
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...